Guy de Martynoff
Directeur Technique/Scientifique/R&D chez Cytune Pharma SAS
Profil
Guy de Martynoff is currently the Chief Technology Officer at Cytune Pharma SAS, a Principal at Remora Partners SA, a Principal at Institute Gustave Rousse, and a Principal at Hôpital Européen Georges-pompidou.
Previously, he worked as a Principal at Fujirebio Europe NV, Executive Vice President at MERISTEM Therapeutics SA in 2008, and as a Principal at BioProtein Technologies SA and DMS Biotechnology Sprl.
Dr. de Martynoff holds a doctorate degree from Vrije Universiteit Brussel.
Postes actifs de Guy de Martynoff
| Sociétés | Poste | Début |
|---|---|---|
Cytune Pharma SAS
 Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Directeur Technique/Scientifique/R&D | - |
Remora Partners SA
 Remora Partners SA Financial ConglomeratesFinance Remora Partners SA operates as an investment advisor. The private company is based in Lausanne, CH. and has subsidiaries in Switzerland and United States. | Corporate Officer/Principal | - |
| Institute Gustave Rousse | Corporate Officer/Principal | - |
| Hôpital Européen Georges-pompidou | Corporate Officer/Principal | - |
Anciens postes connus de Guy de Martynoff
| Sociétés | Poste | Fin |
|---|---|---|
MERISTEM Therapeutics SA
 MERISTEM Therapeutics SA BiotechnologyHealth Technology MERISTEM Therapeutics SA specializes in research and development of therapeutic proteins using plant biotechnology. The firm extracts proteins from plants and seeds and uses them to double as human hemoglobin and antibodies. Its research shows the extracted proteins can assist with the regression of lung, pancreatic and breast cancer. MERISTEM Therapeutics was founded in 1997 and is headquartered in Clermont-Ferrand, France. | Corporate Officer/Principal | 26/12/2008 |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | - |
DMS Biotechnology SRL
 DMS Biotechnology SRL BiotechnologyHealth Technology DMS Biotechnology Sprl develops biotechnology products. The private company is based in Mont-Saint-Guibert, Belgium. | Corporate Officer/Principal | - |
BioProtein Technologies SA
 BioProtein Technologies SA BiotechnologyHealth Technology BioProtein Technologies SA develops recombinant therapeutic proteins and vaccines. Its proprietary technology offers customized packages supplying highly purified biopharmaceuticals. The firm provides pharmaceutical and biotechnology companies with integrated services from gene expression to industrial production of proteins and vaccines in milk. The company was founded on July 1, 1988 by Marc Le Bozec, Louis-Marie Houdebine, Jean-Paul Renard, Bernard Jégou and François Deneux and is headquartered in Jouy-en-Josas, France. | Corporate Officer/Principal | - |
Formation de Guy de Martynoff
| Vrije Universiteit Brussel | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |
MERISTEM Therapeutics SA
MERISTEM Therapeutics SA BiotechnologyHealth Technology MERISTEM Therapeutics SA specializes in research and development of therapeutic proteins using plant biotechnology. The firm extracts proteins from plants and seeds and uses them to double as human hemoglobin and antibodies. Its research shows the extracted proteins can assist with the regression of lung, pancreatic and breast cancer. MERISTEM Therapeutics was founded in 1997 and is headquartered in Clermont-Ferrand, France. | Health Technology |
BioProtein Technologies SA
BioProtein Technologies SA BiotechnologyHealth Technology BioProtein Technologies SA develops recombinant therapeutic proteins and vaccines. Its proprietary technology offers customized packages supplying highly purified biopharmaceuticals. The firm provides pharmaceutical and biotechnology companies with integrated services from gene expression to industrial production of proteins and vaccines in milk. The company was founded on July 1, 1988 by Marc Le Bozec, Louis-Marie Houdebine, Jean-Paul Renard, Bernard Jégou and François Deneux and is headquartered in Jouy-en-Josas, France. | Health Technology |
Cytune Pharma SAS
Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Commercial Services |
DMS Biotechnology SRL
DMS Biotechnology SRL BiotechnologyHealth Technology DMS Biotechnology Sprl develops biotechnology products. The private company is based in Mont-Saint-Guibert, Belgium. | Health Technology |
Remora Partners SA
Remora Partners SA Financial ConglomeratesFinance Remora Partners SA operates as an investment advisor. The private company is based in Lausanne, CH. and has subsidiaries in Switzerland and United States. | Finance |
| Institute Gustave Rousse | |
| Hôpital Européen Georges-pompidou |
